Trial · NCT04530058
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Record mortality | Acute hospitalization up to one year post burn. | Patient mortality will be recorded during hospitalization and outpatient follow-ups. |
| Primary | Record the episodes of sepsis. | daily until discharge (1-4 months post admission depending on severity of injury)] | Patients will be assessed daily for episodes of sepsis. The total number of episodes over the course of hospital stay will be recorded. |
| Primary | Record episodes of infection. | daily until discharge (1-4 months post admission depending on severity of injury)] | Patients will be assessed daily for episodes of infection. The total number of episodes over the course of hospital stay will be recorded. |
| Primary | Record episodes of pneumonia. | daily until discharge (1-4 months post admission depending on severity of injury)] | Patients will be assessed daily for episodes of infection. The total number of episodes over the course of hospital stay will be recorded. |
| Primary | Organ function - Alkaline phosphatase (ALP) | twice weekly until discharge (1-4 months post admission depending on severity of injury)] | Organ function will be assessed by measuring the biomarker: ALP (U/L). |
| Primary | Organ function - Alanine transaminase (ALT) | twice weekly until discharge (1-4 months post admission depending on severity of injury)] | Organ function will be assessed by measuring the biomarker: ALT (U/L). |
| Primary | Organ function - Bilirubin | twice weekly until discharge (1-4 months post admission depending on severity of injury)] | Organ function will be assessed by measuring the biomarker: bilirubin (umol). |
| Primary | Organ function - Blood Urea Nitrogen (BUN) | twice weekly until discharge (1-4 months post admission depending on severity of injury)] | Organ function will be assessed by measuring the biomarker: BUN (mmol). |
| Primary | Organ function - Creatinine | twice weekly until discharge (1-4 months post admission depending on severity of injury)] | Organ function will be assessed by measuring the biomarker: creatinine (umol/L). |
| Secondary | Measures of steady-state resting energy expenditure (REE) | weekly until discharge if a patient is intubated and ventilated (1-4 months post admission depending on severity of injury)] | Metabolic response to injury and illness can be studied by measuring steady-state resting energy expenditure. Hypermetabolism is used as a secondary endpoint as stress-induced diabetes is associated with inflammation and hypermetabolism. |
| Secondary | Perform oral glucose tolerance test | once at discharge from hospital (1-4 months post admission depending on the severity of injury)] | Standard fasting oral glucose tolerance test with an intake of 75 g of glucose. Subsequent measurements (in mg/dl) of glucose in blood, insulin and c-peptide will be conducted over 2 hours. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04530058/registered